FastGlioma: AI Revolutionizing Brain Tumor Surgery in Real-Time

**FastGlioma** is an innovative AI-powered model that offers real-time insights during brain tumor surgery by identifying potentially removable parts of residual tumors in just 10 seconds. This technology, developed by researchers from the University of Michigan and the University of California San Francisco, is set to revolutionize neurosurgery. **FastGlioma** outperformed conventional methods with a 92% accuracy rate and missed high-risk tumor residues just 3.8% of the time compared to 25% in standard practices. **Todd Hollon, M.D.,** emphasized its potential to change neurosurgery by improving the management of patients with diffuse gliomas through rapid and accurate tumor detection. The technology relies on **foundation models** pre-trained with extensive data, including over 11,000 surgical specimens. Using **stimulated Raman histology**, which allows high-resolution optical imaging, FastGlioma delivers reliable results without conventional methods that are often unavailable or unsuitable for certain tumor types. The model's development also minimizes reliance on MRI or fluorescence, facilitating widespread application. With implications beyond gliomas, the AI model could be adapted to detect tumors such as medulloblastoma, ependymoma, and meningiomas. The study highlights the transformative potential of **AI-driven models** like FastGlioma in providing **accessible, cost-effective solutions** and reshaping surgical oncology by extending its application to other cancer types.